An online survival analysis tool to rapidly assess the effect of 22,277 genes on breast cancer prognosis using microarray data of 1,809 patients

Nonparametric Estimation from Incomplete Observations

Kaplan, E. L., & Meier, P. (1992) · Springer series in statistics · doi:10.1007/978-1-4612-4380-9_25 · Cited by 45,239

Nonparametric Estimation from Incomplete Observations

Kaplan, E. L., & Meier, P. (1958) · Journal of the American Statistical Association · doi:10.1080/01621459.1958.10501452 · Cited by 39,158

A Multigene Assay to Predict Recurrence of Tamoxifen-Treated, Node-Negative Breast Cancer

Paik, S., Shak, S., Tang, G., Kim, C., Baker, J. B., Cronin, M. T., Baehner, F. L., Walker, M. G., Watson, D., Park, T., et al. (2004) · New England Journal of Medicine · doi:10.1056/nejmoa041588 · Cited by 6,321

affy—analysis of Affymetrix GeneChip data at the probe level

Gautier, L., Cope, L., Bolstad, B. M., & Irizarry, R. A. (2004) · Bioinformatics · doi:10.1093/bioinformatics/btg405 · Cited by 5,221

Gene-expression profiles to predict distant metastasis of lymph-node-negative primary breast cancer

Wang, Y., Klijn, J. G. M., Zhang, Y., Sieuwerts, A. M., Look, M. P., Yang, F., Talantov, D., Timmermans, M. A. M., Gelder, M. E. M., Yu, J. X., et al. (2005) · The Lancet · doi:10.1016/s0140-6736(05)17947-1 · Cited by 2,831

Gene Expression and Benefit of Chemotherapy in Women With Node-Negative, Estrogen Receptor–Positive Breast Cancer

Paik, S., Tang, G., Shak, S., Kim, C., Baker, J. B., Kim, W., Cronin, M. T., Baehner, F. L., Watson, D., Bryant, J., et al. (2006) · Journal of Clinical Oncology · doi:10.1200/jco.2005.04.7985 · Cited by 2,597

American Society of Clinical Oncology 2007 Update of Recommendations for the Use of Tumor Markers in Breast Cancer

Harris, L. N., Fritsche, H. A., Mennel, R. G., Norton, L., Ravdin, P. M., Taube, S. E., Somerfield, M. R., Hayes, D. F., & Bast, R. C. (2007) · Journal of Clinical Oncology · doi:10.1200/jco.2007.14.2364 · Cited by 2,234

The MicroArray Quality Control (MAQC) project shows inter- and intraplatform reproducibility of gene expression measurements

MAQC Consortium, Shi, L., Shi, L., Reid, L. H., Jones, W. D., Shippy, R., Warrington, J. A., Baker, S. C., Collins, P. J., de Longueville, F., et al. (2006) · Nature Biotechnology · doi:10.1038/nbt1239 · Cited by 2,126

Gene Expression Profiling in Breast Cancer: Understanding the Molecular Basis of Histologic Grade To Improve Prognosis

Sotiriou, C. P., Wirapati, P., Loi, S., Harris, A. L., Fox, S., Smeds, J., Nordgren, H., Farmer, P. J., Praz, V., Haibe‐Kains, B., et al. (2006) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/djj052 · Cited by 2,050

Genes that mediate breast cancer metastasis to the brain

Bos, P. D., Zhang, X. H.-F., Nadal, C., Shu, W., Gomis, R. R., Nguyen, D. X., Minn, A. J., van de Vijver, M. J., Gerald, W. L., Foekens, J. A., et al. (2009) · Nature · doi:10.1038/nature08021 · Cited by 1,863

Survival analysis across the entire transcriptome identifies biomarkers with the highest prognostic power in breast cancer

Győrffy, B. (2021) · Computational and Structural Biotechnology Journal · doi:10.1016/j.csbj.2021.07.014 · Cited by 1,655

Chromosomal instability drives metastasis through a cytosolic DNA response

Bakhoum, S. F., Ngo, B., Laughney, A. M., Cavallo, J.-A., Murphy, C. J., Ly, P., Shah, P., Sriram, R. K., Watkins, T. B. K., Taunk, N. K., et al. (2018) · Nature · doi:10.1038/nature25432 · Cited by 1,593

Cutoff Finder: A Comprehensive and Straightforward Web Application Enabling Rapid Biomarker Cutoff Optimization

Budczies, J., Klauschen, F., Sinn, B. V., Győrffy, B., Schmitt, W., Darb‐Esfahani, S., & Denkert, C. (2012) · PLoS ONE · doi:10.1371/journal.pone.0051862 · Cited by 1,226

Implementing an online tool for genome-wide validation of survival-associated biomarkers in ovarian-cancer using microarray data from 1287 patients

Győrffy, B., Lánczky, A., & Szállási, Z. (2012) · Endocrine Related Cancer · doi:10.1530/erc-11-0329 · Cited by 970

Endogenous tRNA-Derived Fragments Suppress Breast Cancer Progression via YBX1 Displacement

Goodarzi, H., Liu, X., Nguyen, H. C. B., Zhang, S., Fish, L., & Tavazoie, S. F. (2015) · Cell · doi:10.1016/j.cell.2015.02.053 · Cited by 949

Single-cell analysis reveals a stem-cell program in human metastatic breast cancer cells

Lawson, D. A., Bhakta, N. R., Kessenbrock, K., Prummel, K. D., Yu, Y., Takai, K., Zhou, A. Y., Eyob, H., Balakrishnan, S., Wang, C., et al. (2015) · Nature · doi:10.1038/nature15260 · Cited by 908

Correlating transcriptional networks to breast cancer survival: a large-scale coexpression analysis

Clarke, C., Madden, S. F., Doolan, P., Aherne, S. T., Joyce, H., O’Driscoll, L., Gallagher, W. M., Hennessy, B. T., Moriarty, M. J., Crown, J. P., et al. (2013) · Carcinogenesis · doi:10.1093/carcin/bgt208 · Cited by 854

The Warburg effect in tumor progression: Mitochondrial oxidative metabolism as an anti-metastasis mechanism

Lu, J., Tan, M., & Cai, Q. (2014) · Cancer Letters · doi:10.1016/j.canlet.2014.04.001 · Cited by 822

Long noncoding RNA MALAT1 suppresses breast cancer metastasis

Kim, J., Piao, H.-L., Kim, B., Yao, F., Han, Z., Wang, Y., Xiao, Z., Siverly, A. N., Lawhon, S. E., Ton, B. N., et al. (2018) · Nature Genetics · doi:10.1038/s41588-018-0252-3 · Cited by 767

miRpower: a web-tool to validate survival-associated miRNAs utilizing expression data from 2178 breast cancer patients

Lánczky, A., Nagy, Á. M., Bottai, G., Munkácsy, G., Szabó, A., Santarpia, L., & Győrffy, B. (2016) · Breast Cancer Research and Treatment · doi:10.1007/s10549-016-4013-7 · Cited by 759

Prolyl-4-hydroxylase α subunit 2 promotes breast cancer progression and metastasis by regulating collagen deposition

Xiong, G., Deng, L., Zhu, J., Rychahou, P. G., & Xu, R. (2014) · BMC Cancer · doi:10.1186/1471-2407-14-1 · Cited by 759

Distinct EMT programs control normal mammary stem cells and tumour-initiating cells

Ye, X., Tam, W. L., Shibue, T., Kaygusuz, Y., Reinhardt, F., Eaton, E. N., & Weinberg, R. A. (2015) · Nature · doi:10.1038/nature14897 · Cited by 718

Direct targeting of Sec23a by miR-200s influences cancer cell secretome and promotes metastatic colonization

Korpal, M., Ell, B. J., Buffa, F. M., Ibrahim, T., Blanco, M. A., Celià-Terrassa, T., Mercatali, L., Khan, Z., Goodarzi, H., Hua, Y., et al. (2011) · Nature Medicine · doi:10.1038/nm.2401 · Cited by 646

Most Random Gene Expression Signatures Are Significantly Associated with Breast Cancer Outcome

Venet, D., Dumont, J. E., & Detours, V. (2011) · PLoS Computational Biology · doi:10.1371/journal.pcbi.1002240 · Cited by 614

Drug resistance via feedback activation of Stat3 in oncogene-addicted cancer cells

Lee, H.-J., Zhuang, G., Cao, Y., Du, P., Kim, H.-J., & Settleman, J. (2014) · Cancer Cell · doi:10.1016/j.ccr.2014.05.019 · Cited by 555

Integrated analysis of public datasets for the discovery and validation of survival-associated genes in solid tumors

Győrffy, B. (2024) · The Innovation · doi:10.1016/j.xinn.2024.100625 · Cited by 480

Glucocorticoids promote breast cancer metastasis

Obradović, M. M. S., Hamelin, B., Manevski, N., Couto, J. P., Sethi, A., Coissieux, M.-M., Münst, S., Okamoto, R., Kohler, H., Schmidt, A., et al. (2019) · Nature · doi:10.1038/s41586-019-1019-4 · Cited by 462

A breast cancer stem cell niche supported by juxtacrine signalling from monocytes and macrophages

Lu, H., Clauser, K. R., Tam, W. L., Fröse, J., Ye, X., Eaton, E. N., Reinhardt, F., Donnenberg, V. S., Bhargava, R., Carr, S. A., et al. (2014) · Nature Cell Biology · doi:10.1038/ncb3041 · Cited by 467

Immune suppressive landscape in the human esophageal squamous cell carcinoma microenvironment

Zheng, Y., Chen, Z., Han, Y., Li, H., Zou, X., Zhou, B., Hu, R., Hao, J., Bai, S., Xiao, H., et al. (2020) · Nature Communications · doi:10.1038/s41467-020-20019-0 · Cited by 459

MCT-1/miR-34a/IL-6/IL-6R signaling axis promotes EMT progression, cancer stemness and M2 macrophage polarization in triple-negative breast cancer

Weng, Y., Tseng, H., Chen, Y., Shen, P.-C., Haq, A. T. A., Chen, L., Tung, Y., & Hsu, H.-L. (2019) · Molecular Cancer · doi:10.1186/s12943-019-0988-0 · Cited by 454

ROCplot.org: Validating predictive biomarkers of chemotherapy/hormonal therapy/anti‐HER2 therapy using transcriptomic data of 3,104 breast cancer patients

Fekete, J. T., & Győrffy, B. (2019) · International Journal of Cancer · doi:10.1002/ijc.32369 · Cited by 422

HIF-1 regulates CD47 expression in breast cancer cells to promote evasion of phagocytosis and maintenance of cancer stem cells

Zhang, H., Lu, H., Xiang, L., Bullen, J. W., Zhang, C., Samanta, D., Gilkes, D. M., He, J., & Semenza, G. L. (2015) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1520032112 · Cited by 420

GOBO: Gene Expression-Based Outcome for Breast Cancer Online

Ringnér, M., Fredlund, E., Häkkinen, J., Borg, Å., & Staaf, J. (2011) · PLoS ONE · doi:10.1371/journal.pone.0017911 · Cited by 421

Blocking Lactate Export by Inhibiting the Myc Target MCT1 Disables Glycolysis and Glutathione Synthesis

Doherty, J. R., Yang, C., Scott, K. E. N., Cameron, M. D., Fallahi, M., Li, W., Hall, M. A., Amelio, A. L., Mishra, J. K., Li, F., et al. (2013) · Cancer Research · doi:10.1158/0008-5472.can-13-2034 · Cited by 411

Tumour angiogenesis regulation by the miR-200 family

Pecot, C. V., Rupaimoole, R., Yang, D., Akbani, R., Ivan, C., Lu, C., Wu, S. Y., Han, H., Shah, M., Rodriguez‐Aguayo, C., et al. (2013) · Nature Communications · doi:10.1038/ncomms3427 · Cited by 412

TIM-3 regulates CD103+ dendritic cell function and response to chemotherapy in breast cancer

de Mingo Pulido, Á., Gardner, A., Hiebler, S., Soliman, H., Rugo, H. S., Krummel, M. F., Coussens, L. M., & Ruffell, B. (2018) · Cancer Cell · doi:10.1016/j.ccell.2017.11.019 · Cited by 388

Extracellular matrix signatures of human mammary carcinoma identify novel metastasis promoters

Naba, A., Clauser, K. R., Lamar, J. M., Carr, S. A., & Hynes, R. O. (2014) · eLife · doi:10.7554/elife.01308 · Cited by 379

Stemness of the hybrid Epithelial/Mesenchymal State in Breast Cancer and Its Association with Poor Survival

Große-Wilde, A., d’Hérouël, A. F., McIntosh, E., Ertaylan, G., Skupin, A., Kuestner, R. E., del Sol, A., Walters, K., & Huang, S. (2015) · PLoS ONE · doi:10.1371/journal.pone.0126522 · Cited by 383

PROGgeneV2: enhancements on the existing database

Goswami, C. P., & Nakshatri, H. (2014) · BMC Cancer · doi:10.1186/1471-2407-14-970 · Cited by 369

p53 Acts as a Safeguard of Translational Control by Regulating Fibrillarin and rRNA Methylation in Cancer

Marcel, V., Ghayad, S. E., Belin, S., Thérizols, G., Morel, A., Solano-Gonzàlez, E., Vendrell, J. A., Hacot, S., Mertani, H. C., Albaret, M. A., et al. (2013) · Cancer Cell · doi:10.1016/j.ccr.2013.08.013 · Cited by 394

Targeting Breast Cancer Stem Cell State Equilibrium through Modulation of Redox Signaling

Luo, M., Li, S., Brooks, M. D., Jiagge, E. M., Zhu, Y., Buschhaus, J. M., Conley, S. J., Fath, M. A., Davis, A., Gheordunescu, E., et al. (2018) · Cell Metabolism · doi:10.1016/j.cmet.2018.06.006 · Cited by 362

m6A demethylase ALKBH5 inhibits tumor growth and metastasis by reducing YTHDFs-mediated YAP expression and inhibiting miR-107/LATS2–mediated YAP activity in NSCLC

Jin, D., Guo, J., Wu, Y., Yang, L., Wang, X., Du, J., Dai, J., Chen, W., Gong, K., Miao, S., et al. (2020) · Molecular Cancer · doi:10.1186/s12943-020-01161-1 · Cited by 345

ZMYND11 links histone H3.3K36me3 to transcription elongation and tumour suppression

Wen, H., Li, Y., Xi, Y., Jiang, S., Stratton, S. A., Peng, D., Tanaka, K. Y., Ren, Y.-F., Xia, Z., Wu, J., et al. (2014) · Nature · doi:10.1038/nature13045 · Cited by 358

Integrin-β4 identifies cancer stem cell-enriched populations of partially mesenchymal carcinoma cells

Bierie, B., Pierce, S. E., Kröger, C., Stover, D. G., Pattabiraman, D. R., Thiru, P., Donaher, J. L., Reinhardt, F., Chaffer, C. L., Keckesova, Z., et al. (2017) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1618298114 · Cited by 341

Protein kinase C: perfectly balanced

Newton, A. C. (2018) · Critical Reviews in Biochemistry and Molecular Biology · doi:10.1080/10409238.2018.1442408 · Cited by 344

ZEB1 turns into a transcriptional activator by interacting with YAP1 in aggressive cancer types

Lehmann, W., Mossmann, D., Kleemann, J., Mock, K., Meisinger, C., Brummer, T., Herr, R., Brabletz, S., Stemmler, M. P., & Brabletz, T. (2016) · Nature Communications · doi:10.1038/ncomms10498 · Cited by 320

Transcriptional diversity and bioenergetic shift in human breast cancer metastasis revealed by single-cell RNA sequencing

Davis, R. T., Blake, K., Ma, D., Gabra, M. B. I., Hernandez, G. A., Phung, A. T., Yang, Y., Maurer, D., Lefebvre, A. E. Y. T., Alshetaiwi, H. S., et al. (2020) · Nature Cell Biology · doi:10.1038/s41556-020-0477-0 · Cited by 301

Tumour-associated macrophages drive stromal cell-dependent collagen crosslinking and stiffening to promote breast cancer aggression

Maller, O., Drain, A. P., Barrett, A. S., Borgquist, S., Ruffell, B., Zakharevich, I., Pham, T. T. M., Gruosso, T., Kuasne, H., Lakins, J. N., et al. (2020) · Nature Materials · doi:10.1038/s41563-020-00849-5 · Cited by 302

LncRNA NBR2 engages a metabolic checkpoint by regulating AMPK under energy stress

Liu, X., Xiao, Z., Han, L., Zhang, J., Lee, S.-W., Wang, W., Lee, H., Zhuang, L., Chen, J., Lin, H., et al. (2016) · Nature Cell Biology · doi:10.1038/ncb3328 · Cited by 292

Elf5 inhibits the epithelial–mesenchymal transition in mammary gland development and breast cancer metastasis by transcriptionally repressing Snail2

Chakrabarti, R., Hwang, J., Blanco, M. A., Wei, Y., Lukačišin, M., Romano, R. A., Smalley, K., Liu, S., Yang, Q., Ibrahim, T., et al. (2012) · Nature Cell Biology · doi:10.1038/ncb2607 · Cited by 289

Simultaneous Multiplexed Imaging of mRNA and Proteins with Subcellular Resolution in Breast Cancer Tissue Samples by Mass Cytometry

Schulz, D., Zanotelli, V. R., Fischer, J. R., Schapiro, D., Engler, S., Lun, X., Jackson, H. W., & Bodenmiller, B. (2017) · Cell Systems · doi:10.1016/j.cels.2017.12.001 · Cited by 277

Collagen prolyl 4-hydroxylase 1 is essential for HIF-1α stabilization and TNBC chemoresistance

Xiong, G., Stewart, R. L., Chen, J., Gao, T., Scott, T. L., Samayoa, L. M., O’Connor, K. L., Lane, A. N., & Xu, R. (2018) · Nature Communications · doi:10.1038/s41467-018-06893-9 · Cited by 283

Fate-mapping post-hypoxic tumor cells reveals a ROS-resistant phenotype that promotes metastasis

Godet, I., Shin, Y. J., Ju, J. A., Ye, I. C., Wang, G., & Gilkes, D. M. (2019) · Nature Communications · doi:10.1038/s41467-019-12412-1 · Cited by 275

The Multifaceted Roles of Copper in Cancer: A Trace Metal Element with Dysregulated Metabolism, but Also a Target or a Bullet for Therapy

Lelièvre, P., Sancey, L., Coll, J., Deniaud, A., & Busser, B. (2020) · Cancers · doi:10.3390/cancers12123594 · Cited by 278

STAT3, stem cells, cancer stem cells and p63

Galoczová, M., Coates, P. J., & Vojtěšek, B. (2018) · Cellular & Molecular Biology Letters · doi:10.1186/s11658-018-0078-0 · Cited by 272

SALMON: survival analysis learning with multi-omics neural networks on breast cancer

Huang, Z., Zhan, X., Xiang, S., Johnson, T. S., Helm, B., Yu, C. Y., Zhang, J., Salama, P., Rizkalla, M., Han, Z., et al. (2019) · Frontiers in Genetics · doi:10.3389/fgene.2019.00166 · Cited by 262

DNMT1 is essential for mammary and cancer stem cell maintenance and tumorigenesis

Pathania, R., Ramachandran, S., Elangovan, S., Padia, R. N., Yang, P., Cinghu, S., Veeranan‐Karmegam, R., Arjunan, P., Gnana‐Prakasam, J. P., Fulzele, S., et al. (2015) · Nature Communications · doi:10.1038/ncomms7910 · Cited by 260

Ubiquitylation of Autophagy Receptor Optineurin by HACE1 Activates Selective Autophagy for Tumor Suppression

Liu, Z., Chen, P., Gao, H., Gu, Y., Yang, J., Peng, H., Xu, X., Wang, H., Yang, M., Liu, X., et al. (2014) · Cancer Cell · doi:10.1016/j.ccr.2014.05.015 · Cited by 254

Obesity-associated NLRC4 inflammasome activation drives breast cancer progression

Kolb, R., Phan, L., Borcherding, N., Liu, Y., Yuan, F., Janowski, A. M., Xie, Q., Markan, K. R., Li, W., Potthoff, M. J., et al. (2016) · Nature Communications · doi:10.1038/ncomms13007 · Cited by 239

Kinome-Wide RNA Interference Screen Reveals a Role for PDK1 in Acquired Resistance to CDK4/6 Inhibition in ER-Positive Breast Cancer

Jansen, V. M., Bhola, N. E., Bauer, J. A., Formisano, L., Lee, K., Hutchinson, K. E., Witkiewicz, A. K., Moore, P. D., Estrada, M. V., Sanchez, V. M., et al. (2017) · Cancer Research · doi:10.1158/0008-5472.can-16-2653 · Cited by 247

Dissecting the expression landscape of RNA-binding proteins in human cancers

Kechavarzi, B., & Janga, S. C. (2014) · Genome biology · doi:10.1186/gb-2014-15-1-r14 · Cited by 243

Patterns of ribosomal protein expression specify normal and malignant human cells

Guimaraes, J. C., & Zavolan, M. (2016) · Genome biology · doi:10.1186/s13059-016-1104-z · Cited by 251

ATP7A delivers copper to the lysyl oxidase family of enzymes and promotes tumorigenesis and metastasis

Shanbhag, V., Jasmer, K. J., Zhu, S., Martin, A. L., Gudekar, N., Khan, A. A., Ladomersky, E., Singh, K., Weisman, G. A., & Petris, M. J. (2019) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1817473116 · Cited by 237

Identification of Novel Genetic Markers of Breast Cancer Survival

Guo, Q. J., Schmidt, M. K., Kraft, P. L., Canisius, S., Chen, C., Khan, S., Tyrer, J. P., Bolla, M. K., Wang, Q., Dennis, J., et al. (2015) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/djv081 · Cited by 234

Paclitaxel targets FOXM1 to regulate KIF20A in mitotic catastrophe and breast cancer paclitaxel resistance

Khongkow, P., Gomes, A., Gong, C., Man, E. P. S., Tsang, J. W.-H., Zhao, F., Monteiro, L. J., Coombes, R. C., Medema, R. H., Khoo, U., et al. (2015) · Oncogene · doi:10.1038/onc.2015.152 · Cited by 235

Immunological metagene signatures derived from immunogenic cancer cell death associate with improved survival of patients with lung, breast or ovarian malignancies: A large-scale meta-analysis

Garg, A. D., Ruysscher, D. D., & Agostinis, P. (2015) · OncoImmunology · doi:10.1080/2162402x.2015.1069938 · Cited by 230

TRAF4 Promotes TGF-β Receptor Signaling and Drives Breast Cancer Metastasis

Zhang, L., Zhou, F., de Vinuesa, A. G., de Kruijf, E. M., Mesker, W. E., Li, H., Drabsch, Y., Li, Y., Bauer, A., Rousseau, A., et al. (2013) · Molecular Cell · doi:10.1016/j.molcel.2013.07.014 · Cited by 224

TRIB3 supports breast cancer stemness by suppressing FOXO1 degradation and enhancing SOX2 transcription

Yu, J., Sun, W., Wang, Z., Liang, X., Hua, F., Li, K., Lv, X., Zhang, X., Liu, Y., Yu, J., et al. (2019) · Nature Communications · doi:10.1038/s41467-019-13700-6 · Cited by 232

SIRT7 antagonizes TGF-β signaling and inhibits breast cancer metastasis

Tang, X., Shi, L., Xie, N., Liu, Z., Qian, M., Meng, F., Xu, Q.-Y., Zhou, M., Cao, X., Zhu, W., et al. (2017) · Nature Communications · doi:10.1038/s41467-017-00396-9 · Cited by 225

Piezo2 channel regulates RhoA and actin cytoskeleton to promote cell mechanobiological responses

Pardo-Pastor, C., Rubio-Moscardó, F., Vogel-González, M., Serra, S. A., Afthinos, A., Mrkonjić, S., Destaing, O., Abenza, J. F., Fernández‐Fernández, J. M., Trepat, X., et al. (2018) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1718177115 · Cited by 225

Loss of the Par3 Polarity Protein Promotes Breast Tumorigenesis and Metastasis

McCaffrey, L. M., Montalbano, J., Mihai, C., & Macara, I. G. (2012) · Cancer Cell · doi:10.1016/j.ccr.2012.10.003 · Cited by 225

PKD1 Phosphorylation-Dependent Degradation of SNAIL by SCF-FBXO11 Regulates Epithelial-Mesenchymal Transition and Metastasis

Zheng, H., Shen, M., Zha, Y.-L., Li, W., Wei, Y., Blanco, M. A., Ren, G., Zhou, T., Störz, P., Wang, H., et al. (2014) · Cancer Cell · doi:10.1016/j.ccr.2014.07.022 · Cited by 223

Elevated tumor LDLR expression accelerates LDL cholesterol-mediated breast cancer growth in mouse models of hyperlipidemia

Gallagher, E. J., Zelenko, Z., Neel, B. A., Antoniou, I. M., Rajan, L., KASE, N. G., & LeRoith, D. (2017) · Oncogene · doi:10.1038/onc.2017.247 · Cited by 222

A new inhibitor of glucose-6-phosphate dehydrogenase blocks pentose phosphate pathway and suppresses malignant proliferation and metastasis in vivo

Mele, L. L., Paino, F., Papaccio, F., Regad, T., Boocock, D. J., Stiuso, P., Lombardi, A., Liccardo, D., Aquino, G., Barbieri, A., et al. (2018) · Cell Death and Disease · doi:10.1038/s41419-018-0635-5 · Cited by 215

What turns CREB on? And off? And why does it matter?

Steven, A., Friedrich, M., Jank, P., Heimer, N., Budczies, J., Denkert, C., & Seliger, B. (2020) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-020-03525-8 · Cited by 220

PRMT5 Is a Critical Regulator of Breast Cancer Stem Cell Function via Histone Methylation and FOXP1 Expression

Chiang, K., Zielinska, A. E., Shaaban, A. M., Sánchez-Bailón, M. P., Jarrold, J., Clarke, T. L., Zhang, J., Francis, A., Jones, J. L., Smith, S., et al. (2017) · Cell Reports · doi:10.1016/j.celrep.2017.11.096 · Cited by 208

Kinesin Family Deregulation Coordinated by Bromodomain Protein ANCCA and Histone Methyltransferase MLL for Breast Cancer Cell Growth, Survival, and Tamoxifen Resistance

Zou, J. X., Duan, Z., Wang, J., Sokolov, A., Xu, J., Chen, C. Z., Li, J. J., & Chen, H.-W. (2014) · Molecular Cancer Research · doi:10.1158/1541-7786.mcr-13-0459 · Cited by 202

CD74 and intratumoral immune response in breast cancer

Wang, Z., Milne, K., Webb, J. R., & Watson, P. H. (2016) · Oncotarget · doi:10.18632/oncotarget.8610 · Cited by 202

Stromal miR-200s contribute to breast cancer cell invasion through CAF activation and ECM remodeling

Tang, X., Hou, Y., Yang, G., Wang, X., Tang, S., Du, Y.-E., Yang, L., Yu, T., Zhang, H., Zhou, M., et al. (2016) · Cell Death & Differentiation · doi:10.1038/cdd.2015.78 · Cited by 200

Mining expression and prognosis of topoisomerase isoforms in non-small-cell lung cancer by using Oncomine and Kaplan–Meier plotter

Hou, G., Liu, P., Yang, J., & Wen, S. (2017) · PLoS ONE · doi:10.1371/journal.pone.0174515 · Cited by 198

PBX1 Genomic Pioneer Function Drives ERα Signaling Underlying Progression in Breast Cancer

Magnani, L., Ballantyne, E. B., Zhang, X., & Lupien, M. (2011) · PLoS Genetics · doi:10.1371/journal.pgen.1002368 · Cited by 198

A pan-cancer analysis of the oncogenic role of staphylococcal nuclease domain-containing protein 1 (SND1) in human tumors

Cui, X., Zhang, X., Liu, M., Zhao, C., Zhang, N., Ren, Y., Su, C., Zhang, W., Sun, X., He, J., et al. (2020) · Genomics · doi:10.1016/j.ygeno.2020.06.044 · Cited by 194

Extracellular superoxide dismutase and its role in cancer

Griess, B., Tom, E. C., Domann, F. E., & Teoh-Fitzgerald, M. L. T. (2017) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2017.08.013 · Cited by 200

Are Conventional Type 1 Dendritic Cells Critical for Protective Antitumor Immunity and How?

Cancel, J.-C., Crozat, K., Dalod, M., & Mattiuz, R. (2019) · Frontiers in Immunology · doi:10.3389/fimmu.2019.00009 · Cited by 198

Centromere and kinetochore gene misexpression predicts cancer patient survival and response to radiotherapy and chemotherapy

Zhang, W., Mao, J., Zhu, W., Jain, A. K., Liu, K., Brown, J. B., & Karpen, G. H. (2016) · Nature Communications · doi:10.1038/ncomms12619 · Cited by 195

Metastasis-initiating cells induce and exploit a fibroblast niche to fuel malignant colonization of the lungs

Pein, M., Insua‐Rodríguez, J., Hongu, T., Riedel, A., Meier, J., Wiedmann, L., Decker, K., Essers, M. A. G., Sinn, H., Spaich, S., et al. (2020) · Nature Communications · doi:10.1038/s41467-020-15188-x · Cited by 195

A meta-analysis of gene expression-based biomarkers predicting outcome after tamoxifen treatment in breast cancer

Mihály, Z., Kormos, M., Lánczky, A., Dank, M., Budczies, J., Szász, M. A., & Győrffy, B. (2013) · Breast Cancer Research and Treatment · doi:10.1007/s10549-013-2622-y · Cited by 190

Decellularized extracellular matrix scaffolds identify full-length collagen VI as a driver of breast cancer cell invasion in obesity and metastasis

Wishart, A. L., Conner, S. J., Guarin, J. R., Fatherree, J. P., Peng, Y., McGinn, R. A., Crews, R., Naber, S. P., Hunter, M., Greenberg, A. S., et al. (2020) · Science Advances · doi:10.1126/sciadv.abc3175 · Cited by 185

Long noncoding RNA miR503HG, a prognostic indicator, inhibits tumor metastasis by regulating the HNRNPA2B1/NF-κB pathway in hepatocellular carcinoma

Wang, H., Liang, L., Dong, Q., Huan, L., He, J., Li, B., Yang, C. G., Jin, H., Wei, L., Yu, C., et al. (2018) · Theranostics · doi:10.7150/thno.23012 · Cited by 188

FUT8-mediated aberrant N-glycosylation of B7H3 suppresses the immune response in triple-negative breast cancer

Huang, Y., Zhang, H., Li, Z., Du, T., Chen, Y., Wang, Y., Ni, H.-H., Zhang, K., Mai, J., Hu, B., et al. (2021) · Nature Communications · doi:10.1038/s41467-021-22618-x · Cited by 188

Genome-wide reprogramming of the chromatin landscape underlies endocrine therapy resistance in breast cancer

Magnani, L., Stoeck, A., Zhang, X., Lánczky, A., Mirabella, A., Wang, T., Győrffy, B., & Lupien, M. (2013) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1219992110 · Cited by 187

NRF2 Induction Supporting Breast Cancer Cell Survival Is Enabled by Oxidative Stress–Induced DPP3–KEAP1 Interaction

Lu, K., Alcivar, A. L., Ma, J., Foo, T. K., Zywea, S., Mahdi, A., Huo, Y., Kensler, T. W., Gatza, M. L., & Xia, B. (2017) · Cancer Research · doi:10.1158/0008-5472.can-16-2204 · Cited by 181

STRIPAK components determine mode of cancer cell migration and metastasis

Madsen, C. D., Hooper, S., Tozluoǧlu, M., Bruckbauer, A., Fletcher, G., Erler, J. T., Bates, P. A., Thompson, B. J., & Sahai, E. A. (2014) · Nature Cell Biology · doi:10.1038/ncb3083 · Cited by 177

Comparative metabolomics of estrogen receptor positive and estrogen receptor negative breast cancer: alterations in glutamine and beta-alanine metabolism

Budczies, J., Brockmöller, S. F., Müller, B. M., Barupal, D. K., Richter-Ehrenstein, C., Kleine-Tebbe, A., Griffin, J. L., Orešič, M., Dietel, M., Denkert, C., et al. (2013) · Journal of Proteomics · doi:10.1016/j.jprot.2013.10.002 · Cited by 178

Cyclin-dependent kinase 8 mediates chemotherapy-induced tumor-promoting paracrine activities

Porter, D. C., Farmaki, E., Altilia, S., Schools, G. P., West, D. K., Chen, M., Chang, B.-D., Puzyrev, A. T., Lim, C., Rokow-Kittell, R., et al. (2012) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1206906109 · Cited by 177

Site-specific proteasome phosphorylation controls cell proliferation and tumorigenesis.

Guo, X., Wang, X., Wang, Z., Banerjee, S., Yang, J., Huang, L., & Dixon, J. E. (2016) · Nature Cell Biology · doi:10.1038/ncb3289 · Cited by 169

Twist1 promotes breast cancer invasion and metastasis by silencing Foxa1 expression

Xu, Y., Qin, L., Sun, T., Wu, H., He, T., Yang, Z., Mo, Q., Liao, L., & Xu, J. (2016) · Oncogene · doi:10.1038/onc.2016.286 · Cited by 180

ΔNp63-driven recruitment of myeloid-derived suppressor cells promotes metastasis in triple-negative breast cancer

Kumar, S., Wilkes, D. W., Samuel, N., Blanco, M. A., Nayak, A., Alicea-Torres, K. M., Gluck, C. B., Sinha, S., Gabrilovich, D. I., & Chakrabarti, R. (2018) · Journal of Clinical Investigation · doi:10.1172/jci99673 · Cited by 174

WNT10B/β‐catenin signalling induces HMGA2 and proliferation in metastatic triple‐negative breast cancer

Wend, P., Runke, S., Wend, K., Anchondo, B., Yesayan, M. N., Jardon, M. L., Hardie, N., Loddenkemper, C., Ulasov, I. V., Lesniak, M. S., et al. (2013) · EMBO Molecular Medicine · doi:10.1002/emmm.201201320 · Cited by 175

IRAK1 is a therapeutic target that drives breast cancer metastasis and resistance to paclitaxel

Wee, Z. N., Yatim, S. M. J. M., Kohlbauer, V., Feng, M., Goh, J. Y., Bao, Y., Lee, P. L., Zhang, S., Wang, P. P., Lim, E., et al. (2015) · Nature Communications · doi:10.1038/ncomms9746 · Cited by 167

Expression of the MHC Class II Pathway in Triple-Negative Breast Cancer Tumor Cells Is Associated with a Good Prognosis and Infiltrating Lymphocytes

Forero, A., Li, Y., Chen, D., Grizzle, W. E., Updike, K. L., Merz, N. D., Downs-Kelly, E. P., Burwell, T. C., Vaklavas, C., Buchsbaum, D. J., et al. (2016) · Cancer Immunology Research · doi:10.1158/2326-6066.cir-15-0243 · Cited by 176

FOXA1 overexpression mediates endocrine resistance by altering the ER transcriptome and IL-8 expression in ER-positive breast cancer

Fu, X., Jeselsohn, R. M., Pereira, R., Hollingsworth, E. F., Creighton, C. J., Li, F., Shea, M. J., Nardone, A., Angelis, C. D., Heiser, L. M., et al. (2016) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1612835113 · Cited by 172

Chemotherapy-Induced Ca2+ Release Stimulates Breast Cancer Stem Cell Enrichment

Lu, H., Chen, I., Shimoda, L. A., Park, Y., Zhang, C., Tran, L., Zhang, H., & Semenza, G. L. (2017) · Cell Reports · doi:10.1016/j.celrep.2017.02.001 · Cited by 173

miR-105/93-3p promotes chemoresistance and circulating miR-105/93-3p acts as a diagnostic biomarker for triple negative breast cancer

Li, H., Liang, J.-L., Kuo, Y., Lee, H.-H., Calkins, M. J., Chang, H.-T., Lin, F., Chen, Y., Hsu, T., Hsiao, M., et al. (2017) · Breast Cancer Research · doi:10.1186/s13058-017-0918-2 · Cited by 169

Piezo1 forms mechanosensitive ion channels in the human MCF-7 breast cancer cell line

Li, C., Rezania, S., Kammerer, S., Sokolowski, A., DeVaney, T. T. J., Gorischek, A., Jahn, S. W., Hackl, H., Groschner, K., Windpassinger, C., et al. (2015) · Scientific Reports · doi:10.1038/srep08364 · Cited by 169

FOXA1 upregulation promotes enhancer and transcriptional reprogramming in endocrine-resistant breast cancer

Fu, X., Pereira, R., Angelis, C. D., Veeraraghavan, J., Nanda, S., Qin, L., Cataldo, M. L., Sethunath, V., Mehravaran, S., Gutiérrez, C., et al. (2019) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1911584116 · Cited by 167

Epigenetic reprogramming at estrogen-receptor binding sites alters 3D chromatin landscape in endocrine-resistant breast cancer

Achinger-Kawecka, J., Valdés-Mora, F., Luu, P.-L., Giles, K., Caldon, C. E., Qu, W., Nair, S., Soto, S., Locke, W. J., Yeo-Teh, N. S., et al. (2020) · Nature Communications · doi:10.1038/s41467-019-14098-x · Cited by 136

P1-07-18: Expanding an Online Tool for Genome-Wide Validation of Survival-Associated Biomarkers in Breast and Ovarian Cancer Using Microarray Data of 3,862 Patients.

Győrffy, B., Lánczky, A., & Szállási, Z. (2011) · Cancer Research · doi:10.1158/0008-5472.sabcs11-p1-07-18 · Cited by 70

Online biomarker validation of survival-associated biomarkers in breast and ovarian cancer using microarray data of 3,862 patients.

Győrffy, B., Lánczky, A., & Szállási, Z. (2012) · Journal of Clinical Oncology · doi:10.1200/jco.2012.30.15_suppl.10571

Breast cancer classification and prognosis based on gene expression profiles from a population-based study

Sotiriou, C. P., Neo, S.-Y., McShane, L. M., Korn, E. L., Long, P. M., Jazaeri, A. A., Martiat, P., Fox, S. B., Harris, A. L., & Liu, E. T. (2003) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1732912100 · Cited by 2,024

Design and Multiseries Validation of a Web-Based Gene Expression Assay for Predicting Breast Cancer Recurrence and Patient Survival

van Laar, R. K. (2011) · Journal of Molecular Diagnostics · doi:10.1016/j.jmoldx.2010.12.003 · Cited by 12

bc-GenExMiner: an easy-to-use online platform for gene prognostic analyses in breast cancer

Jézéquel, P., Campone, M., Gouraud, W., Guérin‐Charbonnel, C., Leux, C., Ricolleau, G., & Campion, L. (2011) · Breast Cancer Research and Treatment · doi:10.1007/s10549-011-1457-7 · Cited by 410